HELENA LABS' CK-MG TEST SENSITIVITY OF 95.7% FOR MYOCARDIAL INFARCTION
This article was originally published in The Gray Sheet
Executive Summary
HELENA LABS' CK-MG TEST SENSITIVITY OF 95.7% FOR MYOCARDIAL INFARCTION reported by Peter Puleo, MD, Baylor College of Medicine, et al. in a study published in the Sept. 1 issue of The New England Journal of Medicine. Helena Laboratories' test, which measures subforms of creatine kinase MB, is designed to overcome limitations of conventional CK-MB assays such as lengthy test time and lack of sensitivity. The traditional CK-MB test has a sensitivity of 48%, according to the NEJM report